224 related articles for article (PubMed ID: 31581194)
1. Pregnane X receptor activation constrains mucosal NF-κB activity in active inflammatory bowel disease.
Deuring JJ; Li M; Cao W; Chen S; Wang W; de Haar C; van der Woude CJ; Peppelenbosch M
PLoS One; 2019; 14(10):e0221924. PubMed ID: 31581194
[TBL] [Abstract][Full Text] [Related]
2. Patchouli alcohol activates PXR and suppresses the NF-κB-mediated intestinal inflammatory.
Zhang G; Liu M; Song M; Wang J; Cai J; Lin C; Li Y; Jin X; Shen C; Chen Z; Cai D; Gao Y; Zhu C; Lin C; Liu C
J Ethnopharmacol; 2020 Feb; 248():112302. PubMed ID: 31614203
[TBL] [Abstract][Full Text] [Related]
3. Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation.
Garg A; Zhao A; Erickson SL; Mukherjee S; Lau AJ; Alston L; Chang TK; Mani S; Hirota SA
J Pharmacol Exp Ther; 2016 Oct; 359(1):91-101. PubMed ID: 27440420
[TBL] [Abstract][Full Text] [Related]
4. Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis.
Terc J; Hansen A; Alston L; Hirota SA
Eur J Pharm Sci; 2014 May; 55():12-9. PubMed ID: 24486481
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of NF-κB by a PXR-dependent pathway mediates counter-regulatory activities of rifaximin on innate immunity in intestinal epithelial cells.
Mencarelli A; Renga B; Palladino G; Claudio D; Ricci P; Distrutti E; Barbanti M; Baldelli F; Fiorucci S
Eur J Pharmacol; 2011 Oct; 668(1-2):317-24. PubMed ID: 21806984
[TBL] [Abstract][Full Text] [Related]
6. Notoginsenoside R1 attenuates experimental inflammatory bowel disease via pregnane X receptor activation.
Zhang J; Ding L; Wang B; Ren G; Sun A; Deng C; Wei X; Mani S; Wang Z; Dou W
J Pharmacol Exp Ther; 2015 Feb; 352(2):315-24. PubMed ID: 25472953
[TBL] [Abstract][Full Text] [Related]
7. Oridonin Attenuates TNBS-induced Post-inflammatory Irritable Bowel Syndrome via PXR/NF-κB Signaling.
Shao YY; Guo Y; Feng XJ; Liu JJ; Chang ZP; Deng GF; Xu D; Gao JP; Hou RG
Inflammation; 2021 Apr; 44(2):645-658. PubMed ID: 33125572
[TBL] [Abstract][Full Text] [Related]
8. Activation of PXR by alantolactone ameliorates DSS-induced experimental colitis via suppressing NF-κB signaling pathway.
Ren Y; Yue B; Ren G; Yu Z; Luo X; Sun A; Zhang J; Han M; Wang Z; Dou W
Sci Rep; 2019 Nov; 9(1):16636. PubMed ID: 31719637
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation.
Cheng J; Shah YM; Ma X; Pang X; Tanaka T; Kodama T; Krausz KW; Gonzalez FJ
J Pharmacol Exp Ther; 2010 Oct; 335(1):32-41. PubMed ID: 20627999
[TBL] [Abstract][Full Text] [Related]
10. Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression.
Shah YM; Ma X; Morimura K; Kim I; Gonzalez FJ
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1114-22. PubMed ID: 17170021
[TBL] [Abstract][Full Text] [Related]
11. [Expression of zinc finger protein A20 in pediatric inflammatory bowel disease].
Zheng CF; Huang Y
Zhonghua Er Ke Za Zhi; 2011 Apr; 49(4):261-5. PubMed ID: 21624200
[TBL] [Abstract][Full Text] [Related]
12. Possible involvement of the competition for the transcriptional coactivator glucocorticoid receptor-interacting protein 1 in the inflammatory signal-dependent suppression of PXR-mediated CYP3A induction in vitro.
Okamura M; Shizu R; Hosaka T; Sasaki T; Yoshinari K
Drug Metab Pharmacokinet; 2019 Aug; 34(4):272-279. PubMed ID: 31280915
[TBL] [Abstract][Full Text] [Related]
13. Organotin compound DBDCT induces CYP3A suppression through NF-κB-mediated repression of PXR activity.
Li Y; Lin N; Ji X; Mai J; Li Q
Metallomics; 2019 May; 11(5):936-948. PubMed ID: 30848264
[TBL] [Abstract][Full Text] [Related]
14. Plant flavonol isorhamnetin attenuates chemically induced inflammatory bowel disease via a PXR-dependent pathway.
Dou W; Zhang J; Li H; Kortagere S; Sun K; Ding L; Ren G; Wang Z; Mani S
J Nutr Biochem; 2014 Sep; 25(9):923-33. PubMed ID: 24913217
[TBL] [Abstract][Full Text] [Related]
15. Chrysin ameliorates chemically induced colitis in the mouse through modulation of a PXR/NF-κB signaling pathway.
Dou W; Zhang J; Zhang E; Sun A; Ding L; Chou G; Wang Z; Mani S
J Pharmacol Exp Ther; 2013 Jun; 345(3):473-82. PubMed ID: 23536316
[TBL] [Abstract][Full Text] [Related]
16. Pregnane X receptor as a target for treatment of inflammatory bowel disorders.
Cheng J; Shah YM; Gonzalez FJ
Trends Pharmacol Sci; 2012 Jun; 33(6):323-30. PubMed ID: 22609277
[TBL] [Abstract][Full Text] [Related]
17. PXR Functionally Interacts with NF-κB and AP-1 to Downregulate the Inflammation-Induced Expression of Chemokine CXCL2 in Mice.
Okamura M; Shizu R; Abe T; Kodama S; Hosaka T; Sasaki T; Yoshinari K
Cells; 2020 Oct; 9(10):. PubMed ID: 33076328
[TBL] [Abstract][Full Text] [Related]
18. Activation of NF-kappaB in intestinal epithelial cells by E. coli strains isolated from the colonic mucosa of IBD patients.
La Ferla K; Seegert D; Schreiber S
Int J Colorectal Dis; 2004 Jul; 19(4):334-42. PubMed ID: 15103488
[TBL] [Abstract][Full Text] [Related]
19. Artemisinin protects against dextran sulfate-sodium-induced inflammatory bowel disease, which is associated with activation of the pregnane X receptor.
Hu D; Wang Y; Chen Z; Ma Z; You Q; Zhang X; Zhou T; Xiao Y; Liang Q; Tan H; Xiao C; Tang X; Zhang B; Gao Y
Eur J Pharmacol; 2014 Sep; 738():273-84. PubMed ID: 24886881
[TBL] [Abstract][Full Text] [Related]
20. St. John's Wort alleviates dextran sodium sulfate-induced colitis through pregnane X receptor-dependent NFκB antagonism.
Yan T; Luo Y; Xia Y; Hamada K; Wang Q; Yan N; Krausz KW; Ward JM; Hao H; Wang P; Gonzalez FJ
FASEB J; 2021 Nov; 35(11):e21968. PubMed ID: 34644426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
